Cargando…
SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
Diagnostic markers for both colorectal cancer (CRC) and its precursor lesions are lacking. Although aberrant methylation of the secretin receptor (SCTR) gene was observed in CRC, the diagnostic performance has not been evaluated. Therefore, this study aimed to assess and verify the diagnostic value...
Autores principales: | Li, DaPeng, Zhang, Lei, Fu, JinMing, Huang, Hao, Sun, SiMin, Zhang, Ding, Zhao, LiYuan, Ucheojor Onwuka, Justina, Zhao, YaShuang, Cui, BinBin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734158/ https://www.ncbi.nlm.nih.gov/pubmed/32970347 http://dx.doi.org/10.1111/cas.14661 |
Ejemplares similares
-
Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma
por: Huang, Hao, et al.
Publicado: (2021) -
Colorectal cancer patients with CASK promotor heterogeneous and homogeneous methylation display different prognosis
por: Liu, Ying, et al.
Publicado: (2020) -
A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility
por: Onwuka, Justina Ucheojor, et al.
Publicado: (2020) -
Androgen receptor gene methylation related to colorectal cancer risk
por: Xia, Tingting, et al.
Publicado: (2019) -
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer
por: Li, DaPeng, et al.
Publicado: (2019)